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ABSTRACT
Infection associated haemophagocytic syndrome (HPS) is rare and could be potentially fatal. Reactive HPS has been 
reported with various infections including tuberculosis. Tuberculosis associated HPS is more common in adults than in 
children. Severe pancytopenia due to HPS complicating tuberculosis and while on therapy has been rarely described. 
Success of therapy depends on early initiation of treatment. We describe herein a 13-years old girl who developed 
severe pancytopenia while on anti-tuberculous treatment. Her bone marrow aspirate showed trilineage dyspoiesis, 
histiocytes with phagocytosed debris and haemophagocytosis confirming a reactive haemophagocytic syndrome. She 
recovered completely with supportive treatment. J Microbiol Infect Dis 2013;3(4): 211-213
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Anti-tüberküloz tedavisi alan ergen yaştaki bir kız çocuğunda kendiliğinden iyileşen 
hemofagositik sendrom
ÖZET
Enfeksiyon ilişkili hemofagositik sendrom (HPS) nadirdir ve potansiyel olarak ölümcül olabilir. Reaktif HPS, tüberküloz 
dâhil olmak üzere çeşitli enfeksiyonlarla birlikte bildirilmiştir. Tüberküloz ilişkili HPS erişkinlerde çocuklara göre daha 
sık görülür. Tüberküloz tedavisi ile birlikte HPS ilişkili şiddetli pansitopeni nadiren bildirilmiştir. Tedavi başarısı tedavinin 
erken başlamasına bağlıdır. Bu makalede anti-tüberküloz tedavisi sırasında ciddi pansitopeni gelişen 13 yaşında bir kız 
çocuğu sunulmaktadır. Kemik iliği aspirasyonunda trilineage dispoyez, debris fagosite etmiş histiyositler ve reaktif HPS’yi 
gösteren hemofagositoz vardı. Hasta destek tedavisi ile tamamen iyileşti.
Anahtar kelimeler: Tüberküloz, pansitopeni, hemofagositoz, kendiliğinden iyileşme
INTRODUCTION
Haemophagocytic syndrome (HPS) has been re-
ported rarely with tuberculosis. Severe pancytope-
nia due to HPS complicating tuberculosis disease 
as such, after initiation of treatment for tuberculosis 
and resulting in mortality has been rarely reported.1-4 
We describe herein a 13-year-old girl patient devel-
oping severe pancytopenia during anti-tuberculosis 
treatment, bone marrow findings suggesting HPS 
and treatment success.
CASE REPORT
A 13-year-old girl on anti-tuberculosis therapy for 
pleural effusion presented with history of easy fa-
tigability of 15 days duration and swelling of lower 
limbs of one week duration. There was no history of 
cough, fever, chest pain or rash. Two months earlier 
she presented with cough, hemoptysis and chest 
pain along with weight loss. Clinical examination, 
chest X-Ray, pleural fluid analysis and strongly pos-
itive Mantoux test (induration of 20 mm x 20 mm) 
suggested pleural effusion of tuberculosis etiology. 
She was put on rifampicin, isoniazid, pyrazinamide 
and ethambutol. She showed remarkable improve-
ment by 15 days. Her complete blood count (CBC) 
and liver function tests done a month later were 
normal. Chest X-Ray showed partial resolution of 
earlier findings. There was no history of intercurrent 
illness and she gained weight significantly.Yellanthoor R. B, et al. Tuberculosis associated haemophagocytic syndrome 212
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On the second admission she was afebrile, her 
pulse rate was 140/min, respiratory rate (RR) 25/min 
and arterial blood pressure (BP) was 90/60 mmHg. 
She had severe pallor. Her physical examination 
revealed bilateral pitting pedal edema. There was 
no jaundice, cyanosis, clubbing, lymphadenopathy, 
hepatosplenomegaly, and evidence of pleural effu-
sion or ascites. Cardiovascular and central nervous 
system (CNS) examinations were normal. Chest x-
ray showed resolving of the previous consolidation. 
Investigations showed marked anemia (hemoglo-
bin, 3.1 g/dL), reduced total leucocyte count (3200/
mm3) and platelet count (80,000/mm3). Erythrocyte 
sedimentation rate (ESR) was 81 mm/hours. Red 
blood cell (RBC) indices were normal with the red 
blood cell distribution width (RDW) of 11.9%. Periph-
eral blood smear showed normocytic normochromic 
red cells with mild anisopoikilocytosis. No abnormal 
cell was seen. She was transfused with two units 
of packed RBCs. Over the next two days there was 
further reduction in leucocyte count (2330/mm3) and 
platelets (35000/mm3) with clinical bleeding. She 
also developed fever. Her serum electrolytes, cre-
atinine, uric acid, liver function tests, prothrombin 
time (PT) and activated partial thromboplastin time 
(aPTT) were normal. Lactate dehydrogenase (LDH) 
enzyme level was high (438 U/L).
Bone marrow aspiration was performed to 
evaluate the cause for pancytopenia. The mar-
row was hypercellular with trilineage dyspoiesis. 
Myeloid:Erythroid (M:E) ratio was 5.3:1. Marrow 
iron stores were increased. Histiocytes with phago-
cytosed debris, haemophagocytosis and trilineage 
dyspoiesis were seen (Figure 1A, B, C, and D). Re-
active HPS was considered. She was treated with 
packet RBC and platelet transfusions. Anti-tuber-
culosis treatment was continued. She responded 
well to supportive therapy and by day 12 of admis-
sion, blood haemoglobin concentration (13.1 g/dL), 
leucocyte count (9500/mm3) and platelet (153,000/
mm3) were normalised. Anti-tuberculosis medica-
tions were continued and she was discharged. She 
remained asymptomatic during subsequent follow 
up at 2 weeks, 4 weeks and 4 months with normal 
haemoglobin, leucocyte and platelet counts. 
Figure 1. Leishman stain 
of bone marrow aspirate 
smear.  A: many histiocytes 
with hemophagocytosis 
(x100),  B: histiocyte with 
hemophagocytosis (x400), 
C: a histiocyte with hemo-
phagocytosis with dyspoietic 
erythroid precursor (mega-
loblastoid) and myeloid pre-
cursor (abnormal lobations), 
(x400), D: dyspoiesis of ery-
throid and myeloid elements 
(x400) 
DISCUSSION
HPS is characterized by dysregulated proliferation 
of mature histiocytes and uncontrolled phagocyto-
sis of the platelet, erythrocytes, lymphocytes and 
their hematopoietic precursors in the bone marrow 
and other reticuloendothelial system (RES).1-3,5 Sys-
temic manifestations are mainly due to cytopenia 
like in our case. Reactive HPS has been reported 
with various infections including tuberculosis.1-5 Se-
vere HPS developing after initiation of tuberculosis 
treatment was reported by Balkis et al.1 Fulminant 
course and fatal outcome has also been reported.3
The most prominent laboratory abnormalities 
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found.5 In the present case all three cell lines were 
severely affected. Haemolysis, hyperbilirubinemia 
and disseminated intravascular coagulation (DIC) 
may be associated, all of which were absent in our 
case. The serum level of LDH may be elevated as in 
our case. Most patients have hypertriglyceridemia, 
elevated ferritin and low serum fibrinogen. These 
investigations were not done in our case due to fi-
nancial constraints. However, bone marrow showed 
increased iron stores.
Phagocytosis of blood cells and their precur-
sors is a hallmark of haemophagocytic syndromes. 
Hemophagocytosis in the bone marrow was char-
acteristically demonstrated in our case. In addition, 
there was trilineage dyspoiesis. Marked dyseryth-
ropoiesis is not an uncommon phenomenon in 
HPS and can even mask the phagocytic process. 
Haemophagocytosis is achieved mostly by mono-
cytes and macrophages. Excessive activation of 
monocytes may be due to stimulation by high levels 
of activating cytokines. High levels of interferon-γ, 
soluble interleukin-2 receptor, tumor necrosis 
factor-α (TNF-α), interleukin-1, interleukin-6 and in-
terleukin-18 have been demonstrated; suggesting 
that elaboration of activating cytokines by T-helper 
(TH) cells promotes activation of macrophages in 
this disease. In tuberculosis, reactive HPS may re-
sult from a poorly regulated or inappropriate TH1 
response to intracellular pathogens.5
Situations with increased physiological haemo-
phagocytosis have to be considered before making 
the diagnosis of HPS.6 Haemophagocytosis as a 
physiological process may be observed in situa-
tions such as haemolytic and aplastic anemia, graft 
versus host (GVHD) disease following transfusions 
and cytotoxic therapies. But, haemophagocytosis 
in the context of HPS is normally a systemic event 
like in our case. Despite the limitations, morphologi-
cal evidence of haemophagocytosis is still consid-
ered the gold standard in the diagnosis of HPS and 
can be demonstrated in many organs, in particular 
bone marrow, spleen, liver and lymph nodes. Dur-
ing HPS, haemophagocytosis is found consistently 
in organs of the RES.6 
The diagnosis of HPS is based on five of eight 
criteria namely fever, splenomegaly, bicytopenia, 
hypertriglyceridemia  and/or  hypofibrinogenemia, 
haemophagocytosis, low/absent NK-cell-activity, 
hyperferritinemia, and high-soluble interleukin-
2-receptor levels unless family history or molecular 
diagnosis is consistent with HLH. The limitations of 
diagnosing HPS in this patient include not fulfilling 
the five criteria. Systemic manifestations and typical 
bone marrow findings confirmed HPS. Morphologi-
cal evidence of haemophagocytosis is still consid-
ered the gold standard in the diagnosis of HPS.6
Supportive treatment and immunomodulatory 
therapy such as immunoglobulins, steroids and 
chemotherapy are recommended as therapy.1-5 Un-
derlying infection also needs to be treated promptly. 
Success of therapy is likely if initiated early in the 
course of illness. The present case responded well 
to supportive therapy.
In conclusion, severe pancytopenia in tuber-
culosis patients could rarely be due to secondary 
HPS. Early diagnosis and treatment are essential to 
avoid a fatal outcome.
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